Scott Levison - Concepedia

Author

Scott Levison

Also Known As

Andrew Adebayo Fagbemi, S E Levison, S Levison, S. E. Levison, S. Levison, Scott E Levison, Scott E. Levison, Scott Edward Levison, Scott Levison

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Manchester University of Exeter Manchester Royal Infirmary Guy's and St Thomas' NHS Foundation Trust National Health Service

About

Scott Levison is an author at University of Manchester specializing in medicine, immunology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	821
2	Gastroenterology	3	3	788
3	Immunology	3	3	784
4	Allergy	1	1	33
5	Cell Biology	1	1	96

Scott Levison

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study Nicholas A. Kennedy, Graham Heap, Harry Green, The Lancet. Gastroenterology & hepatology InflammationActive Luminal CrohnAnti-tnf Treatment FailureImmunologyClinical Epidemiology	2019	655
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas, Gastroenterology	2019	385
Human monocytes and macrophages regulate immune tolerance via integrin αvβ8–mediated TGFβ activation Aoife Kelly, Sezin Günaltay, Craig P. McEntee, The Journal of Experimental Medicine	2018	116
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study Neil Chanchlani, Simeng Lin, Claire Bewshea, The Lancet. Gastroenterology & hepatology	2024	108
Review: Enteroendocrine cells: Neglected players in gastrointestinal disorders? Gordon W. Moran, F Leslie, Scott Levison, Therapeutic Advances in Gastroenterology InflammationChronic Inflammatory DiseasesFunctional Gastrointestinal DisorderMucosal ImmunologyMedicine	2008	96
Inflammatory cues enhance TGFβ activation by distinct subsets of human intestinal dendritic cells via integrin αvβ8 Thomas M. Fenton, Aoife Kelly, E Shuttleworth, Mucosal Immunology	2016	62
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study Marco Vincenzo Lenti, Scott Levison, Elena Eliadou, Digestive and Liver Disease	2018	57
Colonic transcriptional profiling in resistance and susceptibility to trichuriasis Scott Levison, John McLaughlin, Leo Zeef, Inflammatory Bowel Diseases	2010	38
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study Shaji Sebastian, G Walker, Nicholas A. Kennedy, The Lancet. Gastroenterology & hepatology Covid-19 PandemicGastroenterologyInfection ControlInterventional EndoscopyUlcerative Colitis	2021	37
Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization Mushref Bakri Assas, Scott Levison, Melvyn Little, Clinical & Experimental Immunology Inflammatory Lung DiseaseMouse Tnf-αImmunologyImmune RegulationPathology	2016	33

Page 1